Beckman Coulter`s Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance
(WorldNews Health)

BREA, Calif., Jan. 28, 2020 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States. The sensitivity of the Access PCT assay helps physicians assess critically ill patients in danger of progression to severe sepsis or septic shock-with test results available in under 20 minutes. `When it comes to sepsis, every minute counts. Bringing the Access PCT Assay into our core laboratory automated workflow makes it possible to streamline procalcitonin testing into our routine service to clinical teams,` said Dr. Bernard C. Cook, Ph.D., Chemistry...